Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "6890aa548a215c65672372e1",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "EMPATECH LINA 25/5",
"description": "EMPATECH LINA 25/5 is a pharmaceutical tablet containing a combination of two active ingredients: Empagliflozin 25MG and Linagliptin 5MG. This medication is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. The combination works through complementary mechanisms to improve glycemic control more effectively than either drug alone. Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes the excretion of excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and suppresses glucagon release, particularly after meals. EMPATECH LINA 25/5 is generally prescribed alongside a balanced diet and regular exercise to optimize blood sugar management and reduce the risk of diabetes-related complications such as kidney damage, neuropathy, and cardiovascular issues.\n\nWhat is EMPATECH LINA 25/5?\n\nEMPATECH LINA 25/5 is a prescription medication combining Empagliflozin (25MG) and Linagliptin (5MG) tablets used to manage type 2 diabetes. It helps control elevated blood sugar levels by using dual actions — the removal of glucose via kidneys and improving pancreatic hormone responses. This combination aims to achieve better and sustained glycemic control, often necessary for patients who have inadequate blood sugar control with other treatments.\n\nUses of EMPATECH LINA 25/5\n\nTo improve blood sugar control in adults with type 2 diabetes, particularly when monotherapy is insufficient.\n\nOften used as a second-line therapy after metformin or when metformin is not tolerated.\n\nTo reduce HbA1c (hemoglobin A1c), an important measure of long-term glucose control.\n\nMay help reduce weight and blood pressure as empagliflozin aids in glucose excretion.\n\nSupports comprehensive diabetes management along with diet and exercise.\n\nPrevents or reduces the risk of diabetes-associated complications such as kidney disease, cardiovascular events, and nerve damage.\n\nSide Effects of EMPATECH LINA 25/5\n\nCommon side effects may include urinary tract infections and genital infections due to increased glucose in urine.\n\nIncreased urination and dehydration.\n\nDizziness or lightheadedness, especially when standing up quickly.\n\nHypoglycemia (low blood sugar), though rare with this combination.\n\nGastrointestinal symptoms such as nausea or diarrhea.\n\nPotential increased risk of ketoacidosis (a serious condition related to high blood acids) in rare cases.\n\nAllergic reactions, although uncommon, may occur and require prompt medical attention.\n\nPrecautions Before Using EMPATECH LINA 25/5\n\nInform your healthcare provider if you have kidney disease, liver problems, or a history of urinary tract infections.\n\nNot recommended for type 1 diabetes or diabetic ketoacidosis treatment.\n\nUse with caution if you are pregnant, planning to become pregnant, or breastfeeding.\n\nStay hydrated while on this medication to reduce the risk of dehydration and dizziness.\n\nInform your doctor about any history of pancreatitis or pancreas disorders.\n\nRegular monitoring of kidney function and blood sugar levels is advised during treatment.\n\nAvoid drinking excessive alcohol as it may increase side effects or risk of ketoacidosis.\n\nDrug Interactions: What Drugs Interact with EMPATECH LINA 25/5?\n\nOther antidiabetic medications, such as insulin or sulfonylureas, may increase the risk of hypoglycemia.\n\nDiuretics, blood pressure medications, and lithium may interact and increase side effects.\n\nDrugs that impair kidney function can affect empagliflozin’s efficacy and safety.\n\nCertain enzyme-inducing drugs may reduce linagliptin levels, lowering its effectiveness.\n\nConsult your healthcare provider for a full list of possible interactions and before starting any new medication, including over-the-counter drugs or supplements.\n\nConclusion\n\nEMPATECH LINA 25/5, containing Empagliflozin 25MG and Linagliptin 5MG, is an effective combination medication to treat high blood sugar levels caused by type 2 diabetes. Its dual-action approach targets different physiological mechanisms to improve blood glucose control, helping reduce the risks and complications associated with diabetes. While it is generally well-tolerated, awareness of possible side effects and drug interactions is important. Always use under medical supervision, alongside lifestyle modifications such as diet and exercise, for optimal diabetes management.",
"price": 345.0,
"discountamount": 104.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2154,
"imageuri": "https://productimages.withfloats.com/actual/6890aa58dd0bc098c3220f4c.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6890aa58dd0bc098c3220f4c.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-08-04T12:40:52.619Z",
"updatedon": "2025-08-04T12:40:52.619Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empatech-lina-25-5/2154",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Empagliflozin and Linagliptin Tablets",
"category": "DIABETIC RANGE",
"tags": [
"Empagliflozin and Linagliptin Tablets"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68822dd35b399ba6097ed11b",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "SEIZMET G 0.5 FORTE",
"description": "SEIZMET G0.5 FORTE is a powerful oral antidiabetic medication formulated with a combination of glimepiride and metformin hydrochloride. This dual-action therapy is specifically designed for patients with type 2 diabetes mellitus who are unable to control their blood sugar levels with diet and exercise alone. The combination works in synergy to manage blood glucose effectively, reduce insulin resistance, and improve overall glycemic control.\n\nGlimepiride and metformin hydrochloride tablets are a combination medication used to treat type 2 diabetes. They work by helping the pancreas release more insulin and by reducing the amount of sugar produced by the liver, while also making the body more sensitive to insulin.\n\nWhat is SEIZMET G0.5 FORTE?\nSEIZMET G0.5 FORTE contains two active ingredients:\n\nGlimepiride (0.5 mg): A sulfonylurea class drug that stimulates the beta cells of the pancreas to release insulin.\n\nMetformin Hydrochloride: A biguanide that works primarily by suppressing hepatic glucose production and increasing insulin sensitivity in muscles.\n\nTogether, this combination addresses both insulin deficiency and resistance—two key factors in type 2 diabetes.\n\nUses of SEIZMET G0.5 FORTE:\n\nEffective in managing type 2 diabetes mellitus\n\nHelps in reducing fasting and postprandial blood glucose levels\n\nUsed as monotherapy or in combination with other antidiabetic agents\n\nReduces the risk of diabetic complications such as nephropathy, retinopathy, and cardiovascular disease\n\nSide Effects of SEIZMET G0.5 FORTE:\nLike all medications, glimepiride and metformin hydrochloride tablets may cause side effects in some patients. Common side effects include:\n\nNausea or vomiting\n\nDiarrhea\n\nHypoglycemia (low blood sugar)\n\nHeadache\n\nDizziness\n\nMetallic taste in the mouth\n\nAbdominal discomfort\n\nIn rare cases, it may cause lactic acidosis, a serious condition related to metformin accumulation.\n\nPrecautions Before Using SEIZMET G0.5 FORTE:\n\nAlways take the medication exactly as prescribed by your doctor.\n\nInform your physician if you have a history of liver or kidney disorders, heart disease, or alcohol abuse.\n\nAvoid excessive alcohol consumption while on this medication as it increases the risk of lactic acidosis.\n\nNot recommended for patients with type 1 diabetes or diabetic ketoacidosis.\n\nRegularly monitor your blood sugar and kidney function.\n\nThis medicine should be used during pregnancy only if absolutely necessary and under medical supervision.\n\nDrug Interactions: What Drugs Interact with SEIZMET G0.5 FORTE?\nCertain medications can interact with glimepiride and metformin, affecting their efficacy or increasing the risk of side effects. These include:\n\nBeta-blockers (e.g., propranolol) – may mask hypoglycemia symptoms\n\nDiuretics – may impair blood sugar control\n\nACE inhibitors – may increase the blood glucose-lowering effect\n\nCorticosteroids – may reduce the effectiveness of the medication\n\nAntipsychotics (e.g., olanzapine)\n\nAlcohol – increases the risk of lactic acidosis\n\nCimetidine – may raise metformin levels in the body\n\nAlways inform your healthcare provider about all medications, supplements, or herbal products you are taking.\n\nConclusion:\nSEIZMET G0.5 FORTE is a trusted, effective choice for managing type 2 diabetes, offering the combined benefits of glimepiride and metformin hydrochloride tablets. With dual mechanisms—enhancing insulin secretion and improving insulin sensitivity—it delivers comprehensive glycemic control. When taken as directed and with regular monitoring, SEIZMET G0.5 FORTE can be a valuable part of a diabetic patient’s treatment regimen, contributing to a healthier, more balanced life.\n\nFor best results, pair this medication with a proper diet, regular physical activity, and periodic blood glucose testing. Always consult your healthcare provider for personalized advice.",
"price": 125.0,
"discountamount": 38.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2151,
"imageuri": "https://productimages.withfloats.com/actual/68822dd8296c4d19d55e8535.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68822dd8296c4d19d55e8535.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-07-24T12:57:55.385Z",
"updatedon": "2025-07-24T12:57:55.385Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/seizmet-g-0-5-forte/2151",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "glimepiride and metformin hydrochloride tablets",
"category": "DIABETIC RANGE",
"tags": [
"glimepiride and metformin hydrochloride tablets"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "681c5e9e5a26e4010ea42029",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "ST-GLIPTIN M 100/ 1000",
"description": "ST-GLIPTIN M 100/1000 is an advanced oral antidiabetic medication designed for the effective management of Type 2 Diabetes Mellitus. This powerful combination of Sitagliptin (100 mg) and Metformin Hydrochloride (1000 mg) offers dual action in controlling elevated blood glucose levels, especially in patients who do not respond adequately to metformin or sitagliptin alone. It is intended for adults and is generally used in conjunction with diet and exercise to enhance glycemic control.\n\nKey Ingredients\nSitagliptin (100 mg)\nSitagliptin is a DPP-4 (Dipeptidyl Peptidase-4) inhibitor that increases the levels of incretin hormones, which help regulate blood sugar by increasing insulin release and decreasing glucagon levels.\n\nMetformin Hydrochloride (1000 mg)\nMetformin belongs to the biguanide class of antidiabetics. It works by reducing the amount of sugar produced by the liver and improves the body’s sensitivity to insulin, facilitating better glucose utilization.\n\nKey Benefits\nHelps reduce both fasting and postprandial (after-meal) blood glucose levels effectively\nImproves overall glycemic control in patients with Type 2 diabetes\nCombines two different mechanisms of action for better diabetes management\nMinimizes the risk of hypoglycemia compared to other antidiabetic therapies\nMay support weight neutrality or slight weight loss in diabetic individuals\n\nHow Does It Work?\nST-GLIPTIN M 100/1000 works through a synergistic mechanism by combining two effective antidiabetic agents:\n\nSitagliptin enhances the levels of incretin hormones, which help the pancreas produce more insulin and reduce the secretion of glucagon, especially when blood sugar is high.\nMetformin reduces hepatic glucose production and increases insulin sensitivity, which helps the body use glucose more efficiently.\nTogether, these agents provide comprehensive blood sugar control by addressing multiple physiological pathways involved in glucose metabolism.\n\nDirections for Use\nTake ST-GLIPTIN M 100/1000 exactly as prescribed by your physician.\nIt is typically taken once or twice daily with meals to reduce gastrointestinal side effects and optimize absorption.\nSwallow the tablet whole with water. Do not crush or chew the tablet.\nMaintain a balanced diet and follow an active lifestyle for best results.\nRegular blood sugar monitoring is essential to assess effectiveness and make any necessary dosage adjustments.\n\nSide Effects\nCommon side effects may include nausea, diarrhea, stomach upset, or headache.\nSome individuals may experience respiratory tract infections, sore throat, or a runny nose.\nLactic acidosis is a rare but serious side effect associated with high-dose metformin—seek immediate medical attention if symptoms like unusual fatigue, muscle pain, difficulty breathing, or abdominal discomfort occur.\nAllergic reactions such as rash, itching, or swelling are uncommon but possible.\nAlways inform your doctor of any persistent or bothersome side effects for timely intervention.",
"price": 225.0,
"discountamount": 68.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"1001000 works",
"100 1000stgliptin",
"work stgliptin",
"balanced diet",
"tablet maintain",
"diabetic individuals",
"sitagliptin 100 mg",
"timely intervention",
"rash itching",
"medical attention",
"highdose metforminseek",
"assess effectiveness",
"active lifestyle",
"pancreas produce",
"synergistic mechanism",
"antidiabetic therapies",
"hypoglycemia compared",
"glycemic control",
"biguanide class",
"incretin hormones",
"respond adequately",
"powerful combination",
"insulin facilitating",
"sugar produced",
"side effect",
"bodys sensitivity",
"effective management",
"blood sugar",
"increases insulin sensitivity",
"regulate blood sugar",
"glucose metabolism directions",
"increasing insulin release",
"bothersome side effects",
"diabetes management minimizes",
"optimize absorption swallow",
"slight weight loss",
"support weight neutrality"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2107,
"imageuri": "https://productimages.withfloats.com/actual/681c5e9f5e6dd8f19a0309c3.png",
"tileimageuri": "https://productimages.withfloats.com/tile/681c5e9f5e6dd8f19a0309c3.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-05-08T07:34:54.516Z",
"updatedon": "2025-05-08T07:35:36.782Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/st-gliptin-m-100-1000/2107",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "sitagliptin and metformin hydrochloride tablets",
"category": "DIABETIC RANGE",
"tags": [
"Sitagliptin and Metformin hydrochloride tablets Uses in Hindi",
"sitagliptin and metformin hydrochloride tablets 50/1000 uses in hindi",
"sitagliptin and metformin hydrochloride tablets"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6810aa8d5a26e4010ea41a99",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "EMPATECH MET",
"description": "EMPATECH MET 12.5/500 is a powerful oral antidiabetic combination therapy containing Empagliflozin and Metformin Hydrochloride, designed to manage Type 2 Diabetes Mellitus effectively. This dual-action formula helps control blood sugar levels, supports weight management, and offers added cardiovascular benefits. EMPATECH MET 12.5/500 is particularly beneficial for adults who require a second-line treatment when diet, exercise, and monotherapy are not sufficient.\n\nKey Ingredients\nEmpagliflozin (12.5 mg):\nA sodium-glucose co-transporter-2 (SGLT2) inhibitor that helps reduce blood glucose levels by promoting glucose excretion through urine.\n\nMetformin Hydrochloride (500 mg):\nA biguanide class medication that lowers blood glucose by improving insulin sensitivity and reducing glucose production in the liver.\n\nKey Benefits\nHelps in lowering and maintaining stable blood glucose levels\n\nPromotes weight loss and reduces visceral fat\n\nReduces the risk of cardiovascular complications in diabetic patients\n\nSupports renal protection in people with diabetes and mild kidney dysfunction\n\nOffers a low risk of hypoglycemia compared to some other therapies\n\nImproves glycemic control with a dual mechanism of action\n\nHow Does It Work?\nEMPATECH MET 12.5/500 functions through two complementary mechanisms:\n\nEmpagliflozin works by blocking SGLT2 proteins in the kidneys, reducing the reabsorption of glucose and increasing its excretion via urine. This lowers blood sugar levels independently of insulin action.\n\nMetformin acts primarily by inhibiting hepatic glucose production and improving the body’s sensitivity to insulin, allowing for better uptake and usage of glucose by muscles and fat tissues.\n\nTogether, they provide a comprehensive glycemic control strategy, especially for patients not responding well to monotherapy.\n\nDirections for Use\nTake the tablet as prescribed by your doctor, usually once or twice daily with meals.\n\nSwallow the tablet whole with water; do not crush or chew.\n\nContinue following a healthy diet and regular exercise routine for optimal results.\n\nMonitor blood sugar levels regularly and report any unusual changes to your healthcare provider.\n\nDo not stop the medication without medical advice, even if your blood sugar levels improve.\n\nSide Effects\nCommon Side Effects:\n\nIncreased urination\n\nThirst or dry mouth\n\nNausea or mild gastrointestinal upset\n\nHeadache\n\nFatigue\n\nLess Common but Serious Side Effects:\n\nRisk of urinary tract infections or genital infections\n\nLactic acidosis (rare but serious; associated with Metformin)\n\nDehydration or low blood pressure, especially in elderly patients\n\nElectrolyte imbalances\n\nSeek immediate medical help if you experience severe abdominal pain, muscle cramping, breathing difficulties, or unusual tiredness.",
"price": 155.0,
"discountamount": 47.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"unusual tiredness",
"medical advice",
"monotherapy directions",
"healthcare provider",
"healthy diet",
"chew continue",
"meals swallow",
"fat tissues",
"dual mechanism",
"hypoglycemia compared",
"cardiovascular complications",
"secondline treatment",
"metformin dehydration",
"insulin allowing",
"bodys sensitivity",
"kidneys reducing",
"low risk",
"diet exercise",
"improving insulin sensitivity",
"promoting glucose excretion",
"reducing glucose production",
"side effects risk",
"biguanide class medication",
"lowers blood glucose",
"low blood pressure",
"regular exercise routine",
"metformin hydrochloride designed",
"urinary tract infections",
"dry mouth nausea",
"blocking sglt2 proteins"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2093,
"imageuri": "https://productimages.withfloats.com/actual/6810aa8f5c4a4ba3d41a8c35.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6810aa8f5c4a4ba3d41a8c35.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-04-29T10:31:41.504Z",
"updatedon": "2025-04-29T10:32:46.171Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empatech-met/2093",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Empagliflozin (12.5mg) ,Metformin Hydrochloride (500mg)",
"category": "DIABETIC RANGE",
"tags": [
"empagliflozin 12.5 mg+metformin 500 mg price",
"empagliflozin 12.5 mg+metformin 1000 mg",
"empagliflozin 12.5mg brands in india"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "67e1547f527b20030c4156f0",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin 5 mg and Metformin Hydrochloride 500 mg",
"description": "EMPATECH MET 5/500 is a powerful combination of Empagliflozin 5 mg and Metformin Hydrochloride 500 mg designed to effectively manage Type 2 Diabetes Mellitus. It helps control blood sugar levels, improves insulin sensitivity, and reduces the risk of diabetes-related complications. This dual-action formula works by limiting glucose absorption while enhancing the body's natural ability to utilize insulin, making it a preferred choice for diabetic patients seeking optimal glycemic control.\n \nKey Benefits:\nEffective Blood Sugar Control – Lowers HbA1c levels and maintains stable glucose levels.\nSupports Weight Management – Promotes calorie loss by eliminating excess glucose.\nReduces Cardiovascular Risk – Empagliflozin has heart-protective benefits, reducing the risk of heart-related complications.\nImproves Insulin Sensitivity – Helps the body use insulin more effectively.\nReduces the Risk of Hypoglycemia – Lowers blood sugar without excessive insulin spikes.\n\nHow Does It Work?\n\nEmpagliflozin blocks the SGLT2 (Sodium-Glucose Co-Transporter 2) in the kidneys, preventing glucose reabsorption and allowing excess sugar to be excreted through urine.\nMetformin decreases glucose production in the liver and enhances insulin sensitivity, helping the body use glucose more efficiently.\nTogether, they provide comprehensive diabetes management by regulating blood sugar without causing significant hypoglycemia.\n \nDirections for Use:\n \n\nTake EMPATECH MET 5/500 as prescribed by your doctor.\n\nSwallow the tablet whole with water, preferably with meals to minimize stomach discomfort.\n\nMaintain a balanced diet and regular exercise for optimal results.\n\nDo not stop or change the dosage without consulting your doctor.\n\n \nSide Effects:\n \n\nWhile EMPATECH MET 5/500 is generally well-tolerated, some individuals may experience:\n\nFrequent Urination – Due to glucose excretion in urine.\nMild Stomach Discomfort – Including nausea, bloating, or diarrhea.\nDizziness or Weakness – Especially in the initial stages of treatment.\nUrinary Tract Infections (UTIs) – A possible side effect of increased glucose in urine.\nLactic Acidosis (Rare but Serious) – Symptoms include muscle pain, breathing difficulty, or extreme tiredness; seek medical attention if these occur.",
"price": 115.0,
"discountamount": 35.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"effectively reduces",
"increased glucose",
"initial stages",
"diarrhea dizziness",
"nausea bloating",
"glucose excretion",
"generally welltolerated",
"optimal results",
"regular exercise",
"balanced diet",
"water preferably",
"empatech met 5500",
"preferred choice",
"diabetesrelated complications",
"powerful combination",
"side effect",
"doctor swallow",
"empagliflozin 5mg",
"doctor side effects",
"limiting glucose absorption",
"excessive insulin spikes",
"utilize insulin making",
"work empagliflozin blocks",
"regulating blood sugar",
"allowing excess sugar",
"heartprotective benefits reducing",
"bodys natural ability",
"dualaction formula works"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2074,
"imageuri": "https://productimages.withfloats.com/actual/67e15496bb48c9c5202ecea6.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67e15496bb48c9c5202ecea6.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-03-24T12:47:59.972Z",
"updatedon": "2025-03-27T12:53:02.808Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-5-mg-and-metformin-hydrochloride-500-mg/2074",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "EMPATECH MET 5/500",
"category": "DIABETIC RANGE",
"tags": [
"empagliflozin/metformin 5 mg/1000 mg",
"empagliflozin 12.5 mg+metformin 500 mg price",
"empagliflozin + metformin combination brand name"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "67e152b7204f0ac1d74d3bb7",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin 10 mg, Sitagliptin 100 mg",
"description": "GLIEMPAFLOZIN SITA 10/100 is a powerful combination of Empagliflozin 10 mg and Sitagliptin 100 mg designed to effectively manage Type 2 Diabetes Mellitus. This dual-action formula helps regulate blood sugar levels, improves insulin sensitivity, and supports overall metabolic health. It is ideal for individuals who require an advanced approach to diabetes management while reducing the risk of complications.\n\n \nKey Benefits:\n \n\nEffective Blood Sugar Control – Helps maintain stable glucose levels throughout the day.\nDual-Action Formula – Targets blood sugar from different pathways for enhanced efficacy.\nWeight Management Support – Aids in mild weight loss by reducing excess glucose.\nCardiovascular Protection – May lower the risk of heart-related complications.\nReduces Risk of Hypoglycemia – Less likelihood of sudden blood sugar drops compared to some other diabetes medications.\n\n \nHow Does It Work?\n \n\nEmpagliflozin works by preventing glucose reabsorption in the kidneys, allowing excess sugar to be eliminated through urine.\n\nSitagliptin increases insulin production while reducing the liver’s glucose output, leading to improved blood sugar control.\n\nTogether, these ingredients offer a comprehensive diabetes treatment approach, making it easier to maintain healthy glucose levels.\n\nDirections for Use:\n \n\nTake GLIEMPAFLOZIN SITA 10/100 as prescribed by your doctor.\n\nSwallow the tablet whole with a glass of water.\n\nCan be taken with or without food.\n\nMaintain a balanced diet and regular exercise for best results.\n\nDo not exceed the recommended dosage.\n\n \nSide Effects:\n \n\nWhile generally well-tolerated, some individuals may experience:\n\nIncreased Urination\nMild Nausea or Stomach Discomfort\nHeadache or Dizziness\nUrinary Tract Infections (UTIs)\nLow Blood Pressure (in some cases)\n\nSeek medical attention if you experience severe allergic reactions, dehydration, or persistent discomfort.",
"price": 365.0,
"discountamount": 110.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"generally welltolerated",
"regular exercise",
"balanced diet",
"food maintain",
"doctor swallow",
"gliempaflozin sita 10100",
"ingredients offer",
"diabetes medications",
"diabetes management",
"advanced approach",
"metabolic health",
"powerful combination",
"persistent discomfort",
"empagliflozin 10mg",
"stomach discomfort headache",
"work empagliflozin works",
"preventing glucose reabsorption",
"mild weight loss",
"sitagliptin 100mg designed"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2072,
"imageuri": "https://productimages.withfloats.com/actual/67e152c98868d014155bafa6.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67e152c98868d014155bafa6.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-03-24T12:40:23.819Z",
"updatedon": "2025-03-27T12:58:36.708Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-10-mg-sitagliptin-100-mg/2072",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN SITA 10/100",
"category": "DIABETIC RANGE",
"tags": [
"Empagliflozin and sitagliptin combination",
"Empagliflozin and sitagliptin tablets",
"Empagliflozin and sitagliptin combination brands",
"Empagliflozin and sitagliptin tablets"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "67e151dde76674b1ca044d32",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin 25 mg and Sitagliptin 100 mg",
"description": "GLIEMPAFLOZIN SITA 25/100 is an advanced anti-diabetic medication containing Empagliflozin 25 mg and Sitagliptin 100 mg, formulated to effectively control blood sugar levels in individuals with Type 2 Diabetes Mellitus. This powerful combination helps regulate glucose levels, improve insulin function, and reduce the risk of diabetes-related complications. It is designed for patients requiring dual therapy to achieve better glycemic control.\n\n \nKey Benefits:\n \nEffective Blood Sugar Control – Lowers HbA1c levels and maintains long-term glycemic stability.\nPromotes Weight Loss – Empagliflozin helps in reducing excess body weight by eliminating excess glucose.\nHeart & Kidney Protection – Reduces the risk of cardiovascular diseases and kidney complications.\nEnhanced Insulin Sensitivity – Improves insulin response and minimizes glucose spikes.\nConvenient Dual Therapy – Combines two powerful anti-diabetic agents in one tablet for better diabetes management.\n\n \nHow Does It Work?\n \n\nEmpagliflozin blocks the SGLT2 protein in the kidneys, preventing glucose reabsorption and promoting glucose excretion through urine. This helps lower blood sugar levels naturally while supporting heart and kidney health.\n\nSitagliptin works by inhibiting the DPP-4 enzyme, which increases the levels of incretin hormones that stimulate insulin release and reduce glucose production in the liver.\n\nTogether, they offer comprehensive diabetes control by lowering blood sugar through different mechanisms, making it a superior option for Type 2 Diabetes management.\n\n \nDirections for Use:\n \n\nTake GLIEMPAFLOZIN SITA 25/100 as prescribed by your doctor.\n\nSwallow the tablet whole with water, preferably once daily with or without food.\n\nMaintain a healthy diet and regular exercise for best results.\n\nDo not exceed the recommended dosage without consulting a healthcare professional.\n\n \nSide Effects:\n \n\nWhile generally well-tolerated, some users may experience:\n\nFrequent Urination (due to glucose excretion)\nDehydration & Dizziness\nMild Nausea or Stomach Discomfort\nHypoglycemia (Low Blood Sugar) – Especially if combined with insulin or sulfonylureas\nUrinary or Genital Infections (due to increased sugar excretion in urine)\n\nSeek medical attention if you experience severe allergic reactions, persistent dizziness, or signs of dehydration.",
"price": 425.0,
"discountamount": 128.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"sulfonylureas urinary",
"generally welltolerated",
"recommended dosage",
"regular exercise",
"healthy diet",
"food maintain",
"water preferably",
"doctor swallow",
"gliempaflozin sita 25100",
"superior option",
"mechanisms making",
"incretin hormones",
"dpp4 enzyme",
"supporting heart",
"sglt2 protein",
"diabetes management",
"cardiovascular diseases",
"diabetesrelated complications",
"empagliflozin 25mg",
"reduce glucose production",
"stimulate insulin release",
"work empagliflozin blocks",
"increased sugar excretion",
"genital infections due",
"lowering blood sugar",
"promoting glucose excretion",
"powerful antidiabetic agents",
"sitagliptin 100mg formulated",
"advanced antidiabetic medication"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2071,
"imageuri": "https://productimages.withfloats.com/actual/67e151f4a5330495f6fabda3.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67e151f4a5330495f6fabda3.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-03-24T12:36:45.699Z",
"updatedon": "2025-03-27T13:02:48.654Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-25-mg-and-sitagliptin-100-mg/2071",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN SITA 25/100",
"category": "DIABETIC RANGE",
"tags": [
"Empagliflozin and sitagliptin combination",
"Empagliflozin 25 mg substitute",
"Empagliflozin 25 mg brands in India",
"Empagliflozin 25 mg Price in India",
"Empagliflozin brands in India",
"Empagliflozin 25 mg",
"Empagliflozin"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "67a35691f802c88560805614",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin (10mg)",
"description": "GLIEMPAFLOZIN 10 is a prescription medication containing Empagliflozin (10mg), a highly effective oral antidiabetic drug used to manage type 2 diabetes mellitus (T2DM). It belongs to the class of SGLT2 inhibitors (Sodium-Glucose Co-Transporter 2 Inhibitors) and helps lower blood sugar levels by promoting glucose excretion through urine. This medication is designed to improve glycemic control in adults with diabetes while also offering cardiovascular and renal benefits.\n\n \nKey Benefits:\n \n\nEffective Blood Sugar Control: Helps reduce HbA1c levels, leading to better diabetes management.\n\nWeight Management: May contribute to weight loss by eliminating excess glucose through urine.\n\nHeart Health Benefits: Reduces the risk of cardiovascular complications in diabetic patients.\n\nKidney Protection: Helps in slowing the progression of diabetic nephropathy, offering renal protective benefits.\n\nLower Risk of Hypoglycemia: Since it works independently of insulin, it has a lower risk of causing low blood sugar episodes.\n\nImproves Insulin Sensitivity: Enhances glucose utilization by the body, promoting better metabolic health.\n\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN 10 functions by inhibiting the SGLT2 protein in the kidneys. Normally, this protein facilitates glucose reabsorption in the renal tubules, preventing it from being expelled through urine. By blocking SGLT2, Empagliflozin prevents glucose reabsorption, leading to increased glucose excretion and lower blood sugar levels. Additionally, it reduces blood pressure, body weight, and the risk of cardiovascular diseases, making it a comprehensive treatment option for diabetes.\n\n \nDirections for Use:\n \n\nTake one tablet of GLIEMPAFLOZIN 10 once daily, with or without food, as prescribed by your doctor.\n\nSwallow the tablet whole with a glass of water.\n\nFollow a healthy diet and regular exercise routine alongside medication for optimal results.\n\nDo not skip doses or stop taking the medication without consulting your healthcare provider.\n\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN 10 is well-tolerated, some individuals may experience mild to moderate side effects, including:\n\nFrequent urination due to increased glucose excretion.\n\nDehydration and dizziness, especially in hot weather or when not drinking enough fluids.\n\nUrinary tract infections (UTIs) or genital yeast infections due to higher sugar levels in urine.\n\nLow blood pressure (hypotension) in some patients.\n\nIncreased cholesterol levels in certain cases.\n\nKetoacidosis (rare but serious), which requires immediate medical attention.",
"price": 135.0,
"discountamount": 41.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"gliempaflozin 10",
"lower risk",
"prescription medication",
"diabetes directions",
"medical attention",
"hot weather",
"experience mild",
"stop taking",
"skip doses",
"optimal results",
"healthy diet",
"water follow",
"doctor swallow",
"sglt2 protein",
"metabolic health",
"works independently",
"weight loss",
"empagliflozin 10mg",
"empagliflozin 10mggliempaflozin 10",
"cardiovascular complications",
"offering cardiovascular",
"body promoting",
"cardiovascular diseases making",
"promoting glucose excretion",
"cases ketoacidosis rare",
"higher sugar levels",
"frequent urination due",
"moderate side effects",
"comprehensive treatment option",
"increased glucose excretion",
"renal tubules preventing",
"eliminating excess glucose",
"improve glycemic control"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2042,
"imageuri": "https://productimages.withfloats.com/actual/67a356d6b85688fc926014bf.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67a356d6b85688fc926014bf.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-02-05T12:16:17.708Z",
"updatedon": "2025-03-17T11:05:58.966Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-10mg-/2042",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 10 ",
"category": "DIABETIC RANGE",
"tags": [
"Empagliflozin 10mg price",
"Empagliflozin 10 mg brand name",
"Empagliflozin 10 mg brands in India",
"Empagliflozin side effects",
"Empagliflozin 10 mg vs 25 mg efficacy"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "67122bef263d0316fb4c9dcb",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Gliclazide IP (40 mg) , Pioglitazone Hydrochloride IP (15 mg) , Metformin Hydrochloride IP (500 mg)",
"description": "TRI-GLICLAGLAZE 40 is a powerful oral anti-diabetic medication formulated to manage Type 2 Diabetes Mellitus effectively. This combination of three potent drugs—Gliclazide, Pioglitazone, and Metformin—works synergistically to control high blood sugar levels, improve insulin sensitivity, and help patients achieve better glycemic control. TRI-GLICLAGLAZE 40 is designed for patients who struggle to manage blood glucose levels with single medications or lifestyle changes alone. It is a comprehensive solution for long-term diabetes management and reducing the risk of complications related to uncontrolled blood sugar.\n\n \n\nKey Benefits:\n \n\nEffective Blood Sugar Control: TRI-GLICLAGLAZE 40 helps maintain optimal blood glucose levels by targeting different aspects of diabetes management, such as stimulating insulin release, improving insulin sensitivity, and reducing glucose production.\nReduces Insulin Resistance: Pioglitazone and Metformin work together to lower insulin resistance, making it easier for the body to use insulin effectively.\nImproves Long-Term Glycemic Control: By combining three active ingredients, this medication is particularly beneficial for those struggling with glycemic control through diet or monotherapy alone.\nReduces Risk of Diabetes Complications: Controlling blood sugar levels helps prevent diabetes-related complications such as nerve damage, kidney disease, and cardiovascular problems.\nSupports Weight Management: Metformin, in particular, has been known to assist with weight management, which is important for patients with Type 2 Diabetes.\n \n\nHow Does It Work?\n \nTRI-GLICLAGLAZE 40 works through a multi-faceted mechanism to lower blood glucose levels:\n\nGliclazide stimulates the beta cells in the pancreas to release more insulin, which lowers blood sugar levels post-meal.\n\nPioglitazone enhances the body's sensitivity to insulin by promoting glucose uptake in the muscle and fat cells while also decreasing glucose production in the liver.\n\nMetformin reduces the production of glucose in the liver and improves insulin sensitivity. It also decreases the absorption of sugar from the intestines, ensuring better blood sugar control throughout the day.\n\nThis combination of ingredients targets multiple pathways involved in glucose regulation, making it an effective option for individuals with Type 2 Diabetes who require more comprehensive blood sugar control.\n\n \n\nDirections for Use:\n \nTake TRI-GLICLAGLAZE 40 exactly as prescribed by your doctor.\nUsually, it is taken once or twice daily with meals to minimize gastrointestinal discomfort.\nSwallow the tablet whole with water—do not crush or chew the tablet.\nContinue following your diet and exercise plan alongside the medication to achieve optimal blood sugar control.\nDo not skip doses, and consult your healthcare provider if you miss a dose.\n \n\nSide Effects:\n \nLike any medication, TRI-GLICLAGLAZE 40 may cause side effects, although not everyone experiences them. Some common and mild side effects include:\n\nHypoglycemia (Low Blood Sugar): Due to Gliclazide’s insulin-stimulating properties, low blood sugar may occur, especially if meals are skipped or exercise is excessive.\n\nGastrointestinal Issues: Metformin is known to cause digestive problems in some individuals, including nausea, vomiting, diarrhea, or stomach cramps.\n\nWeight Gain: Pioglitazone may cause weight gain in some users due to increased fat storage.\n\nFluid Retention: Pioglitazone may lead to water retention, especially in patients with heart conditions, increasing the risk of heart failure.\n\nHeadache and dizziness: These may occur as the body adjusts to the medication, but they are generally mild and temporary.\n\nLactic Acidosis (rare): A serious but rare side effect of Metformin, this condition requires immediate medical attention and is characterized by muscle pain, breathing difficulties, and weakness.\n\n ",
"price": 145.0,
"discountamount": 43.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"fat cells",
"beta cells",
"muscle pain",
"fat storage",
"Weight Gain",
"nerve damage",
"Key Benefits",
"exercise plan",
"Gliclazide IP",
"heart failure",
"stomach cramps",
"kidney disease",
"glucose uptake",
"water retention",
"insulin release",
"Lactic Acidosis",
"Fluid Retention",
"Low Blood Sugar",
"heart conditions",
"rare side effect",
"multiple pathways",
"different aspects",
"lifestyle changes",
"Weight Management",
"mild side effects",
"Insulin Resistance",
"digestive problems",
"single medications",
"glucose production",
"glucose regulation",
"three potent drugs",
"insulin sensitivity",
"healthcare provider",
"breathing difficulties",
"Diabetes Complications",
"comprehensive solution",
"Metformin Hydrochloride",
"Gastrointestinal Issues",
"multi-faceted mechanism",
"cardiovascular problems",
"high blood sugar levels",
"Type 2 Diabetes Mellitus",
"three active ingredients",
"uncontrolled blood sugar",
"Long-Term Glycemic Control",
"gastrointestinal discomfort",
"immediate medical attention",
"optimal blood sugar control",
"optimal blood glucose levels",
"Pioglitazone Hydrochloride IP",
"long-term diabetes management",
"Effective Blood Sugar Control",
"diabetes-related complications",
"insulin-stimulating properties",
"comprehensive blood sugar control",
"powerful oral anti-diabetic medication"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1994,
"imageuri": "https://productimages.withfloats.com/actual/67122bf4ac30f07ce03345d7.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67122bf4ac30f07ce03345d7.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-10-18T09:35:43.008Z",
"updatedon": "2024-10-18T09:35:43.008Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/gliclazide-ip-40-mg-pioglitazone-hydrochloride-ip-15-mg-metformin-hydrochloride-ip-500-mg-/1994",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TRI - GLICLAGLAZE 40 ",
"category": "DIABETIC RANGE",
"tags": [
"gliclazide+metformin hydrochloride tablets uses",
"Gliclazide Metformin Pioglitazone brand name",
"Gliclazide and Metformin hydrochloride tablets Use",
"Gliclazide and Metformin Hydrochloride tablets pri",
"Gliclazide and Metformin Hydrochloride Tablets bra",
"Gliclazide 80 mg and Metformin Hydrochloride table",
"",
""
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}